Antofagasta plc (LON:ANTO – Get Free Report) has been assigned an average recommendation of “Hold” from the seven analysts that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is GBX 1,948.57 ($24.56).
A number of research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Antofagasta from GBX 2,100 ($26.47) to GBX 2,000 ($25.20) and set a “hold” rating for the company in a research note on Monday, September 9th. JPMorgan Chase & Co. dropped their price objective on shares of Antofagasta from GBX 1,730 ($21.80) to GBX 1,720 ($21.68) and set an “underweight” rating for the company in a research note on Wednesday, September 11th.
Check Out Our Latest Research Report on ANTO
Antofagasta Price Performance
Antofagasta Cuts Dividend
The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Thursday, September 5th were issued a dividend of $0.08 per share. The ex-dividend date was Thursday, September 5th. This represents a dividend yield of 0.32%. Antofagasta’s payout ratio is 4,406.78%.
About Antofagasta
Antofagasta plc operates as a mining company. It operates through Los Pelambres, Centinela, Antucoya, Zaldívar, Exploration and Evaluation, and Transport Division segments. Its mines produce copper cathodes and copper concentrates; and molybdenum, gold, and silver by-products. The company also has exploration projects in various countries.
Read More
- Five stocks we like better than Antofagasta
- How to Invest in Small Cap Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What is a buyback in stocks? A comprehensive guide for investors
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Following Congress Stock Trades
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Antofagasta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antofagasta and related companies with MarketBeat.com's FREE daily email newsletter.